Want to Double Your TFSA? 2 Growth Stocks to Look Into

Consider investing in these two stocks in your TFSA to enjoy high-growth potential in your tax-advantaged account.

| More on:
IMAGE OF A NOTEBOOK WITH TFSA WRITTEN ON IT

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

The Tax-Free Savings Account (TFSA) truly is a blessing for Canadian investors who know how to get the best out of its tax-advantaged status. TFSA investing allows you to grow your wealth without incurring any income tax on your investment returns, whether it is through capital gains or shareholder dividends.

Additionally, you can comfortably enjoy tax-free withdrawals due to the flexibility of the TFSA. Tax-free withdrawals make the TFSA an excellent way to create another income stream to supplement your monthly income. However, there is another way you can use the tax-advantaged status of the account to grow your wealth.

Allocating a portion of your TFSA contribution room to growth stocks can offer you the opportunity to enjoy compounded returns that can accelerate your wealth growth. Today, I will discuss two TSX growth stocks that you could consider for this purpose and potentially double your investment through tax-free gains.

Nuvei

Nuvei (TSX:NVEI)(NASDAQ:NVEI) is a high-growth stock that has been on a downturn for the last few months. The Montreal-based $10.44 billion market capitalization electronic payments processing company is the largest private and non-bank payments processor in the country. It has operations in 200 markets worldwide, supporting over 500 local and alternative payment methods.

The growth in e-commerce and digital transactions has made its services invaluable, and its geographical expansion has made it a popular payments processing company worldwide. The company boasts an immense long-term growth potential, but the broader pullback in growth stocks has led to its decline, despite a strong performance.

At writing, Nuvei stock trades for $73.09 per share, and it is down by over 58% from its September 2021 high. It could be an excellent stock to consider for long-term gains when it gradually recovers on the stock market.

WELL Health Technologies

WELL Health Technologies (TSX:WELL) is another high-growth stock that has become too cheap to ignore now. The $945.21 million market capitalization stock has suffered from a significant drop in its performance on the stock market, despite delivering strong operating and financial performance over the last several quarters.

The tech-based healthcare company has posted a positive adjusted EBITDA in its past few quarters, making it a strong contender to consider.

At writing, WELL Health stock trades for $4.54 per share. It is down by 43.04% in the last 12 months of trading, despite its terrific operational performance due to the broader decline in the tech industry. Investing in its shares at current levels could set you up for significant wealth growth through capital gains when the stock likely recovers.

Foolish takeaway

Investing in the right high-quality growth stocks at reasonable valuations can provide you with significant long-term returns. Allocating a portion of your TFSA contribution room to such high-growth assets could help you enjoy those returns without losing a big chunk to income taxes.

If you have the contribution room to spare in your TFSA, investing in Nuvei stock and WELL Health stock could be an excellent way for you to deploy your investment capital for wealth growth.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Adam Othman has no position in any of the stocks mentioned. The Motley Fool owns and recommends Nuvei Corporation.

More on Investing

Investing

KM Throwaway Post

Read more »

Investing

Carlos Test Yoast Metadata

Read more »

Investing

KM Ad Test

This is my excerpt.

Read more »

Investing

Test post for affiliate partner mockups

Updated: 9/17/2024. This post was not sponsored. The views and opinions expressed in this review are purely those of the…

Read more »

Investing

Testing Ecap Error

Premium content from Motley Fool Stock Advisor We here at Motley Fool Stock Advisor believe investors should own at least…

Read more »

Investing

TSX Today: Testing the Ad for James

la la la dee dah.

Read more »

Lady holding remote control pointed towards a TV
Investing

2 Streaming Stocks to Buy Now and 1 to Run From

There are streaming stocks on the TSX that are worth paying attention to in 2023 and beyond.

Read more »

A red umbrella stands higher than a crowd of black umbrellas.
Stocks for Beginners

Top Recession-Resilient TSX Stocks to Buy With $3,000

It's time to increase your exposure to defensives!

Read more »